Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

PROVAS - Treatment of coronary heart disease and other clinical conditions relating to a deficit in endothelial progenitor cells

12.05.2009
Endothelial progenitor cells are bone-marrow-derived cells that circulate in the blood and have the ability to differentiate into endothelial cells. The amount of

endothelial progenitor cells is affected by numerous factors. A decreased number and function of endothelial progenitor cells was observed in patients suffering from different disorders. The reason for decreased levels of endothelial progenitor cells and the clinical effect still remains unclear. Experimental therapy of a deficit of endothelial progenitor cells currently is limited to infusion of endothelial progenitor cells or stem cells. Such infusions are complex and the therapeutic success at present is limited. The adenosine level especially in the blood plasma can affect the level of endothelial progenitor cells. Adenosine level affecting-compounds can increase the viability of endothelial progenitor cells. It is of particular therapeutic value that adenosine level affecting-compounds can induce an increase of the level of endothelial progenitor cells and at the same time can reduce the amount of apoptotic endothelial progenitor cells. The present invention discloses the use of adenosine level affecting-compounds e.g. dipyridamole, adenosine and its analogues (alone or in combination with other groups of compounds) for the t reatment or diagnosis of clinical conditions resulting from a deficit of endothelial progenitor cells, especially coronary heart disease.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=1573&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Microarray to determine responsiveness of tumors to antiangiogenic treatment
06.12.2016 | TechnologieAllianz e.V.

nachricht Peltier Adsorption Trap
29.11.2016 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>